Medtech Insights

Novel monitoring technologies, changes in CMS reimbursement guidelines, influxes of newly insured patients, and US health demographics will result in a modest expansion of the overall US patient…

The US and European markets for breast implants and reconstructive devices will grow modestly through 2024, driven primarily by expansion of the US market, which accounts for the majority of total…

The global market for HA viscosupplementation will exhibit moderate growth through 2024, driven by rising use of this treatment, especially in the Asia Pacific region. While premium-priced single…

As Europe continues to grapple with the financial pressure and austerity measures introduced by the Eurozone crisis, revenue growth in the PACS, RIS, and CVIS market will increasingly be…

Moderate expansion of the global breast biopsy device market will be driven primarily by the increasing use of premium-priced VAB devices, as well as growth in procedure volumes resulting from…

The Asia Pacific gynecological device market will continue to expand through 2024 due to greater adoption of treatments for gynecological conditions as well as the adoption of minimally invasive…

The Asia Pacific orthopedic extremity device market will grow at a rapid pace through 2024, primarily as a result of favorable demographics, increasing penetration into existing eligible…

Although market growth will be dampened due to tepid economic conditions early in the forecast period, the European facial injectable market will expand at a moderate pace through 2024, fueled by…

The Latin American dental biomaterial market remains underpenetrated; as a result there is significant opportunity for manufacturers to expand into this region. Increasing manufacturer presence in…

While current volatile economic conditions in Latin America will limit the dental implant market in regions such as Argentina and Brazil, expansion into underpenetrated regional markets, such as…

The Asia Pacific orthopedic extremity device market will grow at a rapid pace through 2024, primarily as a result of favorable demographics, increasing penetration into existing eligible…

The Asia Pacific gynecological device market will continue to expand through 2024 due to greater adoption of treatments for gynecological conditions as well as continued marketing efforts and…